Stock listing
Lang & Schwarz:A1W7Q9 Celyad Oncology SA Aktie
German listing (Lang & Schwarz) of Celyad Oncology SA · home listing Euronext:CYAD
Follow Celyad Oncology SA into a list and get an email when it puts out news.
Home listing price · EURONEXT:CYAD
€0.20 EUR -0.01 (-4.8%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:CYAD
- Day range
- €0.20 – €0.206 EUROct 30, 2026
- Volume
- 6,719 sharesOct 30, 2026
- Market cap
- €14.98M EURAt the close on Oct 30, 2026 · price × 74.88M shares outstanding
- 52-week range
- €0.16 – €0.65 EURLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- €2,969 EURMedian day 9,615 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:CYAD · Home | €0.20 EUR | -0.01 (-4.8%) | 6,719 | €0.206 | €0.206 | €0.20 | €0.21 | Close on Oct 30, 2026 |
| Frankfurt:1C0 | €0.17 EUR | +0.003 (+1.8%) | — | €0.17 | €0.17 | €0.17 | €0.167 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · EURONEXT:CYAD · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €0.20 | -0.01 | -4.8% | €0.206 | €0.206 | €0.20 | 6,719 | |
| €0.21 | 0.00 | 0.0% | €0.21 | €0.21 | €0.206 | 853 | |
| €0.21 | 0.00 | 0.0% | €0.206 | €0.21 | €0.206 | 12,282 | |
| €0.21 | +0.003 | +1.4% | €0.206 | €0.21 | €0.206 | 11,777 | |
| €0.207 | -0.017 | -7.6% | €0.22 | €0.22 | €0.207 | 1,249 | |
| €0.224 | +0.016 | +7.7% | €0.206 | €0.224 | €0.206 | 1,731 | |
| €0.208 | -0.017 | -7.6% | €0.208 | €0.208 | €0.208 | 8 | |
| €0.225 | +0.015 | +7.1% | €0.206 | €0.225 | €0.206 | 8,431 | |
| €0.21 | +0.004 | +1.9% | €0.225 | €0.225 | €0.21 | 221 | |
| €0.206 | -0.021 | -9.3% | €0.205 | €0.224 | €0.205 | 1,277 | |
| €0.227 | +0.013 | +6.1% | €0.213 | €0.228 | €0.205 | 11,850 | |
| €0.214 | +0.008 | +3.9% | €0.206 | €0.214 | €0.206 | 9,667 | |
| €0.206 | -0.014 | -6.4% | €0.22 | €0.22 | €0.206 | 4,359 | |
| €0.22 | +0.01 | +4.8% | €0.23 | €0.23 | €0.21 | 15,270 | |
| €0.21 | +0.01 | +5.0% | €0.21 | €0.22 | €0.21 | 1,906 | |
| €0.20 | -0.03 | -13.0% | €0.20 | €0.20 | €0.20 | 430 | |
| €0.23 | +0.011 | +5.0% | €0.219 | €0.23 | €0.20 | 26,697 | |
| €0.219 | -0.001 | -0.5% | €0.219 | €0.225 | €0.219 | 6,792 | |
| €0.22 | 0.00 | 0.0% | €0.219 | €0.229 | €0.219 | 3,605 | |
| €0.22 | -0.005 | -2.2% | €0.22 | €0.23 | €0.219 | 19,748 | |
| €0.225 | +0.005 | +2.3% | €0.22 | €0.229 | €0.22 | 7,218 | |
| €0.22 | -0.001 | -0.5% | €0.224 | €0.229 | €0.22 | 43,440 | |
| €0.221 | -0.007 | -3.1% | €0.228 | €0.228 | €0.221 | 16,683 | |
| €0.228 | +0.003 | +1.3% | €0.229 | €0.229 | €0.22 | 10,048 | |
| €0.225 | -0.01 | -4.3% | €0.234 | €0.235 | €0.22 | 20,948 | |
| €0.235 | -0.014 | -5.6% | €0.234 | €0.25 | €0.234 | 12,368 | |
| €0.249 | 0.00 | 0.0% | €0.25 | €0.25 | €0.235 | 5,655 | |
| €0.249 | +0.018 | +7.8% | €0.231 | €0.254 | €0.231 | 8,084 | |
| €0.231 | -0.019 | -7.6% | €0.235 | €0.263 | €0.231 | 18,663 | |
| €0.25 | +0.01 | +4.2% | €0.23 | €0.25 | €0.23 | 3,306 | |
| €0.24 | -0.001 | -0.4% | €0.23 | €0.241 | €0.23 | 785 | |
| €0.241 | +0.001 | +0.4% | €0.258 | €0.264 | €0.237 | 33,511 | |
| €0.24 | -0.023 | -8.7% | €0.239 | €0.245 | €0.23 | 4,026 | |
| €0.263 | +0.037 | +16.4% | €0.248 | €0.266 | €0.23 | 17,077 | |
| €0.226 | -0.034 | -13.1% | €0.26 | €0.26 | €0.226 | 38,279 | |
| €0.26 | 0.00 | 0.0% | €0.26 | €0.272 | €0.26 | 667 | |
| €0.26 | -0.013 | -4.8% | €0.26 | €0.272 | €0.26 | 683 | |
| €0.273 | +0.011 | +4.2% | €0.262 | €0.273 | €0.26 | 9,779 | |
| €0.262 | -0.011 | -4.0% | €0.274 | €0.274 | €0.261 | 2,057 | |
| €0.273 | +0.013 | +5.0% | €0.26 | €0.273 | €0.26 | 2,163 | |
| €0.26 | -0.001 | -0.4% | €0.273 | €0.273 | €0.26 | 1,335 | |
| €0.261 | -0.012 | -4.4% | €0.26 | €0.261 | €0.26 | 282 | |
| €0.273 | -0.001 | -0.4% | €0.26 | €0.273 | €0.26 | 1,539 | |
| €0.274 | +0.013 | +5.0% | €0.261 | €0.274 | €0.261 | 1,369 | |
| €0.261 | 0.00 | 0.0% | €0.261 | €0.269 | €0.261 | 15,919 | |
| €0.261 | -0.01 | -3.7% | €0.27 | €0.27 | €0.261 | 8,559 | |
| €0.271 | +0.01 | +3.8% | €0.277 | €0.277 | €0.26 | 22,588 | |
| €0.261 | +0.004 | +1.6% | €0.273 | €0.278 | €0.256 | 21,999 | |
| €0.257 | -0.005 | -1.9% | €0.256 | €0.278 | €0.255 | 32,008 | |
| €0.262 | -0.016 | -5.8% | €0.256 | €0.275 | €0.256 | 4,849 | |
| €0.278 | -0.003 | -1.1% | €0.271 | €0.284 | €0.255 | 36,512 | |
| €0.281 | +0.008 | +2.9% | €0.275 | €0.287 | €0.27 | 28,243 | |
| €0.273 | -0.017 | -5.9% | €0.29 | €0.29 | €0.265 | 5,752 | |
| €0.29 | +0.011 | +3.9% | €0.279 | €0.29 | €0.258 | 47,001 | |
| €0.279 | +0.011 | +4.1% | €0.269 | €0.28 | €0.253 | 21,344 | |
| €0.268 | -0.001 | -0.4% | €0.268 | €0.268 | €0.254 | 11,808 | |
| €0.269 | -0.001 | -0.4% | €0.27 | €0.27 | €0.26 | 2,717 | |
| €0.27 | 0.00 | 0.0% | €0.269 | €0.271 | €0.256 | 14,110 | |
| €0.27 | +0.014 | +5.5% | €0.258 | €0.273 | €0.253 | 15,141 | |
| €0.256 | -0.014 | -5.2% | €0.246 | €0.27 | €0.246 | 10,939 | |
| €0.27 | +0.022 | +8.9% | €0.246 | €0.27 | €0.236 | 3,173 | |
| €0.248 | -0.002 | -0.8% | €0.226 | €0.248 | €0.226 | 2,067 | |
| €0.25 | -0.01 | -3.8% | €0.261 | €0.282 | €0.239 | 23,412 | |
| €0.26 | -0.013 | -4.8% | €0.273 | €0.273 | €0.26 | 10,131 | |
| €0.273 | +0.012 | +4.6% | €0.26 | €0.273 | €0.26 | 9,615 | |
| €0.261 | -0.01 | -3.7% | €0.271 | €0.283 | €0.261 | 19,045 | |
| €0.271 | -0.002 | -0.7% | €0.289 | €0.289 | €0.27 | 26,349 |
- Ticker
- Lang & Schwarz:A1W7Q9
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Sep 23, 2026
Celyad Oncology Reports First Half Year 2026 Results
Latest news
Celyad Oncology Reports First Half Year 2026 Results
Sep 23, 2026
Closed €0.249 (0.0%) on Sep 24, 2026
Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
Jul 22, 2026
Closed €0.264 (+5.6%) on Jul 23, 2026
Celyad Oncology Announces €500,000 Private Placement
Jul 14, 2026
Closed €0.25 (+1.6%) on Jul 14, 2026
Celyad Oncology Reports Full Year 2025 Financial Results and Business Highlights
Apr 2, 2026
Closed €0.328 (+2.5%) on Apr 7, 2026
Celyad Oncology Announces the Sale of C-CATHez ® Catheter
Feb 12, 2026
Closed €0.272 (+23.1%) on Feb 12, 2026
Financings
Private placement of capital increase (shares)
Sep 23, 2026 · US$569,630
Closed: €500,000 raised · €0.2 a share
Buyers: CFIP CLYD (UK) Limited (€500,000 for 2,500,000 shares; expected to hold approximately 60.52% of outstanding shares and approximately 68.75% of voting rights); an affiliate of Fortress Investment Group (2,500,000 new shares)
Insiders: Fortress, a related party through its shareholding and board representation, is the subscriber; its nominated directors did not take part in the board deliberations or votes.
Use of proceeds: Working capital and general corporate purposes
Announced Jul 14, 2026 · Closed Jul 22, 2026 · Closed Sep 23, 2026
Decks
Investor Presentation (January 2023)
Investor deck · 15 slides · January 2023
Corporate Update (December 2021)
Corporate update · 28 slides · Dec 13, 2021
Technical Presentation (July 2021)
Technical · 51 slides · Jul 21, 2021
European Hematology Association Virtual Congress 2021
Conference · 24 slides · Jun 11, 2021
Celyad Oncology SA on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 7 in the last 12 months · 25 in all · newest Sep 23, 2026 · oldest 2023
- Decks
- 13 decks · latest January 2023
Where Celyad Oncology SA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:CYAD · Home listing | Euronext | Belgium | EUR |
| LS Exchange:A1W7Q9 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A1W7Q9 · This page | Lang & Schwarz | Germany | EUR |
| LSE:0QFK | LSE | United Kingdom | EUR |
| OTC:CLYYF | OTC | United States | USD |
| Turquoise:CYADB | Turquoise | United Kingdom | EUR |
| Aquis:CYADB | Aquis | United Kingdom | EUR |
| Aquis:CYADB | Aquis | United Kingdom | EUR |
| Dusseldorf:1C0 | Dusseldorf | Germany | EUR |
| Frankfurt:1C0 | Frankfurt | Germany | EUR |
| Munich:1C0 | Munich | Germany | EUR |
| Stuttgart:1C0 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Celyad Oncology SA.